|
Heart Valve
Introduction
The tilting- disc Heart Valve, after successful
clinical trials is now commercially available, an indigenously
developed remedy which holds a lot of promise for persons
with Heart Valve problems especially those suffering from
rheumatic heart diseases, for blocked or leaking aortal and
mitral passages in the heart. The technology, conceived and
crafted by the Sree Chitra Tirunal Institute of Medical Sciences
and Technology (SCTIMST), Thiruvananthapuram, was transferred
by the funding agency, the National Research Development Corporation
(NRDC) to TTK Pharma for commercial exploitation based on
its experience in the big?medical devices field. The heart
valve's launch is a culmination of more than 15 years of painstaking
research and development TTK Pharma is the third company in
the world to produce such a heart valve. Artificial heart
valves implanted in patients in India (many of them are children
who suffer from rheumatic fever) till two years back were
imported at a price which rang
Raw Materials:
In the Indian context, the durability
of the valve is of paramount importance because the average
age of RHO patients is between 20 and 30 years, whereas in
the developed countries patients are mostly
Contact
for more information
Director
National Research Development Corporation
20-22, Zamroodpur Community CentreKailash Colony Extension
New Delhi, India
Delhi 110048
Tel: 11 6449401/6460506
Fax: 11 6432121/6449396
Email: info@nrdcindia.com

|